For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240722:nRSV2974Xa&default-theme=true
RNS Number : 2974X Morgan Stanley & Co. Int'l plc 22 July 2024
22 July 2024
Not for distribution, directly or indirectly, in or into the United States or
any jurisdiction in which such distribution would be unlawful.
Sani/Ikos Financial Holdings 1 S.A.R.L.
Post-stabilisation Period Announcement
Further to the pre-stabilisation period announcement dated 16 July 2024,
MORGAN STANLEY & CO. INTERNATIONAL PLC (contact: Joseph Bishay; telephone:
+44 20 7677-0230) hereby gives notice, that no stabilisation (within the
meaning of Article 3.2(d) of the EU Market Abuse Regulation (596/2014),
including as it forms part of domestic law by virtue of the European Union
(Withdrawal) Act 2018) was undertaken by the Stabilisation Manager(s) named
below in relation to the offer of the following securities.
Securities
Issuer: Sani/Ikos Financial Holdings 1 S.A.R.L.
Guarantor(s) (if any): Sani/Ikos Group NewCo S.C.A. and Sani/Ikos Financial Holdings 2 S.A.R.L.
Aggregate nominal amount: €350,000,000
Description: €350,000,000 Senior Notes due 2030
ISIN: Reg S: XS2864440321
144A: XS2864440594
Offer price: Par
Stabilisation
Stabilisation Manager: MORGAN STANLEY & CO. INTERNATIONAL PLC
This announcement is for information purposes only and does not constitute an
invitation or offer to underwrite, subscribe for or otherwise acquire or
dispose of any securities of the Issuer in any jurisdiction.
This announcement is not an offer of securities for sale into the United
States. The securities referred to above have not been, and will not be,
registered under the United States Securities Act of 1933 and may not be
offered or sold in the United States absent registration or an exemption from
registration. There will be no public offer of securities in the United
States.
END.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END STARTMMTMTTTBRI